छोड़कर सामग्री पर जाएँ
Hold Bandhan Bank; target of Rs 193: KR Choksey

Hold Bandhan Bank; target of Rs 193: KR Choksey

  • द्वारा
  • Latest News

KR Choksey recommended hold rating on Bandhan Bank with a target price of Rs 193 in its research report dated April 08, 2024.

Read More

​ KR Choksey recommended hold rating on Bandhan Bank with a target price of Rs 193 in its research report dated April 08, 2024. KR Choksey recommended hold rating on Bandhan Bank with a target price of Rs 193 in its research report dated April 08, 2024.  Moneycontrol Latest News Read More  

KR Choksey recommended hold rating on Bandhan Bank with a target price of Rs 193 in its research report dated April 08, 2024.

Sensex @ 75,000: These stocks missed the 5,000-point run through 82 days

Sensex @ 75,000: These stocks missed the 5,000-point run through 82 days

  • द्वारा
  • Latest News

The biggest loser among these stocks was HDFC Bank, declining around 6.6 percent. Other notable declines include Hindustan Unilever and Asian Paints, falling around 4.6 percent and 2.7 percent respectively. Additionally, stocks such as ITC, Axis Bank, Kotak Mahindra Bank, Bajaj Finance, Bajaj Finserv, Infosys, and Nestle India also saw declines ranging from 0.2 to 2.4 percent

Read More

​ The biggest loser among these stocks was HDFC Bank, declining around 6.6 percent. Other notable declines include Hindustan Unilever and Asian Paints, falling around 4.6 percent and 2.7 percent respectively. Additionally, stocks such as ITC, Axis Bank, Kotak Mahindra Bank, Bajaj Finance, Bajaj Finserv, Infosys, and Nestle India also saw declines ranging from 0.2 to 2.4 percent The biggest loser among these stocks was HDFC Bank, declining around 6.6 percent. Other notable declines include Hindustan Unilever and Asian Paints, falling around 4.6 percent and 2.7 percent respectively. Additionally, stocks such as ITC, Axis Bank, Kotak Mahindra Bank, Bajaj Finance, Bajaj Finserv, Infosys, and Nestle India also saw declines ranging from 0.2 to 2.4 percent  Moneycontrol Latest News Read More  

The biggest loser among these stocks was HDFC Bank, declining around 6.6 percent. Other notable declines include Hindustan Unilever and Asian Paints, falling around 4.6 percent and 2.7 percent respectively. Additionally, stocks such as ITC, Axis Bank, Kotak Mahindra Bank, Bajaj Finance, Bajaj Finserv, Infosys, and Nestle India also saw declines ranging from 0.2 to 2.4 percent

James Bullard says three Fed rate cuts this year is ‘base case’

James Bullard says three Fed rate cuts this year is ‘base case’

  • द्वारा
  • Latest News

“At this point, you should probably take the committee and chair at face value — their best guess right now is still three cuts this year,� Bullard said Tuesday in an interview with Bloomberg TV. “That’s the base case.�

Read More

​ â€œAt this point, you should probably take the committee and chair at face value — their best guess right now is still three cuts this year,â€� Bullard said Tuesday in an interview with Bloomberg TV. “That’s the base case.â€� “At this point, you should probably take the committee and chair at face value — their best guess right now is still three cuts this year,â€� Bullard said Tuesday in an interview with Bloomberg TV. “That’s the base case.â€�  Moneycontrol Latest News Read More  

“At this point, you should probably take the committee and chair at face value — their best guess right now is still three cuts this year,� Bullard said Tuesday in an interview with Bloomberg TV. “That’s the base case.�

India likely to get normal monsoon this year: Skymet

India likely to get normal monsoon this year: Skymet

  • द्वारा
  • Latest News

Monsoon rains are expected to be 102% of the long-period average of 868.6 mm for the four-month period, Skymet said.

Read More

​ Monsoon rains are expected to be 102% of the long-period average of 868.6 mm for the four-month period, Skymet said. Monsoon rains are expected to be 102% of the long-period average of 868.6 mm for the four-month period, Skymet said.  Moneycontrol Latest News Read More  

Monsoon rains are expected to be 102% of the long-period average of 868.6 mm for the four-month period, Skymet said.

US junks 200 years of economics to block China clean tech

US junks 200 years of economics to block China clean tech

  • द्वारा
  • Latest News

The Treasury secretary is rejecting fundamental principles to justify a policy of restricting public access to affordable and clean technology. Her plan is a protectionist disaster that will impede the path to net zero

Read More

​ The Treasury secretary is rejecting fundamental principles to justify a policy of restricting public access to affordable and clean technology. Her plan is a protectionist disaster that will impede the path to net zero The Treasury secretary is rejecting fundamental principles to justify a policy of restricting public access to affordable and clean technology. Her plan is a protectionist disaster that will impede the path to net zero  Moneycontrol Latest News Read More  

The Treasury secretary is rejecting fundamental principles to justify a policy of restricting public access to affordable and clean technology. Her plan is a protectionist disaster that will impede the path to net zero

Strides Pharma gets USFDA nod for antidepressant medication

Strides Pharma gets USFDA nod for antidepressant medication

  • द्वारा
  • Latest News

The company#39;s Singapore-based step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has received approval for Fluoxetine Tabs (10 and 20 mg) from the US Food Drug Administration (USFDA), the drug firm said in a regulatory filing.

Read More

​ The company#39;s Singapore-based step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has received approval for Fluoxetine Tabs (10 and 20 mg) from the US Food Drug Administration (USFDA), the drug firm said in a regulatory filing. The company#39;s Singapore-based step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has received approval for Fluoxetine Tabs (10 and 20 mg) from the US Food Drug Administration (USFDA), the drug firm said in a regulatory filing.  Moneycontrol Latest News Read More  

The company#39;s Singapore-based step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has received approval for Fluoxetine Tabs (10 and 20 mg) from the US Food Drug Administration (USFDA), the drug firm said in a regulatory filing.

Natco Pharma gets warning letter from USFDA for Telangana plant

Natco Pharma gets warning letter from USFDA for Telangana plant

  • द्वारा
  • Latest News

The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the company#39;s Kothur-based formulation facility.

Read More

​ The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the company#39;s Kothur-based formulation facility. The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the company#39;s Kothur-based formulation facility.  Moneycontrol Latest News Read More  

The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the company#39;s Kothur-based formulation facility.

FO Manual | Bulls charge indices to record highs, experts advocate buying on dips

FO Manual | Bulls charge indices to record highs, experts advocate buying on dips

  • द्वारा
  • Latest News

The overall range for the coming few sessions could be 22,950 on the upside and 22,550 on the downside.

Read More

​ The overall range for the coming few sessions could be 22,950 on the upside and 22,550 on the downside. The overall range for the coming few sessions could be 22,950 on the upside and 22,550 on the downside.  Moneycontrol Latest News Read More  

The overall range for the coming few sessions could be 22,950 on the upside and 22,550 on the downside.

Buy Godrej Consumer Products; target of Rs 1455: Sharekhan

Buy Godrej Consumer Products; target of Rs 1455: Sharekhan

  • द्वारा
  • Latest News

Sharekhan is bullish on Godrej Consumer Products has recommended buy rating on the stock with a target price of Rs 1455 in its research report dated April 08, 2024.

Read More

​ Sharekhan is bullish on Godrej Consumer Products has recommended buy rating on the stock with a target price of Rs 1455 in its research report dated April 08, 2024. Sharekhan is bullish on Godrej Consumer Products has recommended buy rating on the stock with a target price of Rs 1455 in its research report dated April 08, 2024.  Moneycontrol Latest News Read More  

Sharekhan is bullish on Godrej Consumer Products has recommended buy rating on the stock with a target price of Rs 1455 in its research report dated April 08, 2024.

Midcaps may lag largecaps, beware of ‘buzzword’ themes: Aashish Somaiyaa of WhiteOak AMC

Midcaps may lag largecaps, beware of ‘buzzword’ themes: Aashish Somaiyaa of WhiteOak AMC

  • द्वारा
  • Latest News

It has become fashionable to say elections and the upcoming Budget are priced in, says the CEO of WhiteOak Capital AMC. There is substantial upside potential in the coming months, which shouldn#39;t be overlooked or underestimated, he says.

Read More

​ It has become fashionable to say elections and the upcoming Budget are priced in, says the CEO of WhiteOak Capital AMC. There is substantial upside potential in the coming months, which shouldn#39;t be overlooked or underestimated, he says. It has become fashionable to say elections and the upcoming Budget are priced in, says the CEO of WhiteOak Capital AMC. There is substantial upside potential in the coming months, which shouldn#39;t be overlooked or underestimated, he says.  Moneycontrol Latest News Read More  

It has become fashionable to say elections and the upcoming Budget are priced in, says the CEO of WhiteOak Capital AMC. There is substantial upside potential in the coming months, which shouldn#39;t be overlooked or underestimated, he says.

hi_INहिन्दी